• Costa Rica Coffee Guide

Federation Campaigns Against Generic Drugs

September 16, 2005

IN a subtle break from its message last year, the Central American Federation of Pharmaceutical Laboratories (FEDEFARMA) is pushing a pro-name-brand drug campaign that calls into question the quality of generic drugs.Last year, then-president of FEDEFARMA, Rodolfo Lambour, stressed that generic drugs are not inferior, saying, “We have nothing against the concept of generic medicine,” and that they are legitimate, less-costly alternatives when tested properly (TT, Oct. 22, 2004).Now, the federation’s campaign in Costa Rica and Guatemala frames name brand drugs as safer and higher-quality.“The goal of this campaign is to let consumers know what is implied in the quality of a pharmaceutical product and what risks are associated with the purchase of a product that has not demonstrated its quality,” current federation president Christian Naumann said.FEDEFARMA, which represents multinational drug companies including Bayer, Pfizer and Bristol-Meyers Squibb, most of which produce original – not generic – drugs, launched its campaign Sept. 7, and revealed its plans to wire service EFE yesterday.“In our countries, unfortunately, to make it on the health registry, a generic pharmaceutical product is not required to verify its quality or faithfulness to the design of the original,” Naumann said.“Our authorities do not demand studies of bioequivalency or bioavailability.”Bioavailability refers to the amount of the active ingredient in any formula and how it disperses itself in the body, and bioequivalency refers to the proof that the generic product is the same as the original in terms of its effect on the body and its dosage.Some countries have moved forward with proper testing laws, Naumann said, including Costa Rica, which established a regulation that will take effect in February. One drawback to requiring such tests of generic drugs is that it could raise the cost to the consumer. The alternative, however, is uncertainty, at best, and death at worst. Last year a generic blood anti-coagulant called Warfarin was the suspected culprit in the deaths of three patients with mechanical heart valves (TT, Oct. 22, 2004).

You may be interested

Costa Rica registers uptick in visitors in March
Costa Rica
2 views
Costa Rica
2 views

Costa Rica registers uptick in visitors in March

Alejandro Zúñiga - April 16, 2021

Costa Rica welcomed nearly 90,000 international arrivals in March, a significant increase compared with the first two months of 2021,…

Why Costa Rica is re-applying driving restrictions
Costa Rica
1949 views
Costa Rica
1949 views

Why Costa Rica is re-applying driving restrictions

The Tico Times - April 16, 2021

Costa Rica will restart its weekend daytime driving restrictions beginning this Saturday. Click here for all the details. The Presidency…

Costa Rica to restart weekend driving restrictions
Costa Rica
1944 views
Costa Rica
1944 views

Costa Rica to restart weekend driving restrictions

Alejandro Zúñiga - April 16, 2021

Costa Rica will restart its weekend daytime driving restrictions beginning this Saturday, April 17. On Saturdays, only vehicles with license…